We have experience in wide range of disease areas, many of which are not current conflicts. The following is not an exhaustive list! Please click on the titles for further information.
- Angina
- A pre-launch pan-European KOL advocacy and medical education programme for CV Therapeutics
- Anti-viral therapy
- Data announcements from congress and at key publication milestones
- Establishment of global patient support group, led by international panel of experts, to raise awareness of herpes and its appropriate management
- Cardiovascular
- Global communications programme for Tracleer® (bosentan) in the orphan disease area of pulmonary arterial hypertension on behalf of Actelion Pharmaceuticals. A wide ranging programme of activities includes patient education, congress symposium development and implementation, media relations for medical and consumer journalists, KOL development and internal communications
- Metabolic disorders
- On-going global communications support for Zavesca in Niemann-Pick Type C disease
- Pulmonary Hypertension
- On-going global communications support for Tracleer in pulmonary arterial hypertension plus data announcements for Actelion pipeline products
- Respiratory disease
- Internal communications support for GSK’s respiratory franchise plus data outreach activities
- Sleep disorder
- Phase II data outreach and internal communications for almorexant, Actelion’s pipeline product for sleep disorder
